YAYaşar Altun

Yaşar Altun

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yaşar Altun has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Semra Bulbuloglu

    Istanbul Aydın University, Health Sciences Faculty, Nursing Department, İstanbul, Turkey

    2 shared publications
  • Abdullah Algın

    Department of Emergency Medicine, University of Health Sciences Ümraniye Training and Research Hospital, Istanbul, Türkiye

    1 shared publication
  • Ali Zeynal Abidin Tak

    Adıyaman University, Faculty of Medicine, Dept. of Neurology, Adıyaman

    1 shared publication
  • Erdogan Yasar

    Department of Cardiology, Medical Faculty of Adiyaman University, Adiyaman, Turkey

    1 shared publication
  • Erman Altunışık

    Adiyaman University, Training and Research Hospital, Department of Neurology, Adiyaman

    1 shared publication
  • Esra Inan

    Department of Dermatology, Medical Faculty of Adiyaman University, Adiyaman, Turkey

    1 shared publication

Latest Publications

  • Validity and reliability characteristics of the Silhouettes Fatigue Scale in measuring multiple sclerosis‐related fatigue in Turkish‐speaking adults

    by İsA Cüce, Yaşar Altun

    The purpose of this study is to investigate the reliability and validity as well as the clinical utility of the Silhouettes Fatigue Scale (SFS), a single-item visual scale to assess fatigue, in adult patients with multiple sclerosis (MS). The study included 61 MS patients and 73 matched healthy controls. Demographic data and disease-related variables of all participants were recorded. Then, the SFS, Visual Analogue Scale (VAS)-fatigue, Fatigue Impact Scale (FIS), Fatigue Severity Scale (FSS), and Beck Depression Inventory (BDI) were applied. SFS, VAS-fatigue, and FSS were repeated after one week. Reliability was evaluated with the intra-class correlation coefficient (ICC) and Bland-Altman analysis. Validity was tested by comparison of healthy controls and patients with MS and correlations with other scales. Accuracy and clinical utility were also evaluated. SFS scores were 4.49 ± 3.11 (mean ± SD) in MS patients and 1.40 ± 1.44 in healthy controls (p < .001). The ICC for SFS was 0.946. The mean difference between test-retest measurements of SFS was -0.04651 (-95% CI, -0.4815-0.38848), and there was no systemic bias. SFS scores were not correlated with the expanded disability status scale, whereas they were poorly correlated with BDI. Correlations ranging from poor to good were calculated between the SFS and other fatigue-related scales. The optimum cut-off score of the SFS scale was four, with a sensitivity of 0.72 and a specificity of 0.84. This study demonstrated that the SFS is a reliable, responsive, and valid scale with acceptable sensitivity and specificity to assess and quantify clinically significant fatigue in MS patients. These findings as well as the brief and understandable nature of the SFS were encouraging that this scale has good clinical utility.


  • The effect of starting a meal with salt and date palm on taste impairment caused by COVID-19

    by Yasar Altun, Semra Bulbuloglu

    This study was conducted to examine the effect of starting a meal with salt and date palm on the sense of taste in COVID-19 patients. This study was conducted using a randomized controlled method. Patient and disease information forms and Visual Analog Scale were used for data collection. Salt and date palm were used to stimulate the sense of taste in two different experimental groups. No procedure was made in the control group except for the practice of the clinic. The results were analyzed using SPSS version 25. The mean ages of all groups were between 43.42 ± 8.60 and 47.22 ± 12.04 years. Fever, sore throat, dry mouth, cough, muscle weakness, and similar symptoms were present in all groups. Significant improvements were found in patients with hypoageusia and ageusia after date palm and salt application (p<0.01). For taste impairment caused by COVID-19, consumption of date palm and tasting very little salt for therapeutic purposes may help to alleviate taste impairment. Based on the data obtained from this study, the pathophysiology of the effects of date palm and salt on taste complications should be investigated.

  • THE EFFECT OF SNIFFING TURKISH COFFEE ON OLFACTORY DISORDERS IN COVID-19 PATIENTS: AN EXPERIMENTAL CLINICAL STUDY

    by Semra Bulbuloglu, Yasar Altun

    Background and purpose - The current study aimed to examine the effect of sniffing Turkish coffee on the sense of smell in COVID-19 patients. Methods - This study utilized the experiment- control method. Data were collected using a patient and disease information form and the Connecticut Chemosensory Clinical Research Center (CCCRC) Test. An experimental group of patients sniffed Turkish coffee, and the coffee's effect on the patients' sense of smell was examined. All data were analyzed using SPSS version 25 (IBM). Results - Of the patients in the experimental group, 25% had moderate hyposmia, 58.3% had severe hyposmia, and 16.7% had anosmia prior to sniffing Turkish coffee. After sniffing the Turkish coffee, 13.3% of these patients regained their ability to smell normally, while 18.3% had mild hyposmia, 45% had moderate hyposmia, 6.7% had severe hyposmia, and 16.7% had anosmia. There was no difference in the control group between first and second measurement. Conclusion - COVID-19 patients who sniffed Turkish coffee intermittently regained some of their sense of smell for one hour. Turkish coffee is cheap, fragrant, widely available, and easy to access. Therefore, results of this study suggest that it may be recommended for treating olfactory disorder in COVID-19 patients.


  • A valproinsav, a carbamazepin és a levetiracetam hatása a Tp-e intervallumra, valamint a Tp-e/QT és a Tp-e/QTc arányra

    by Yasar Altun, Erdogan Yasar

    To evaluate P-wave dispersion before and after antiepileptic drug (AED) treatment as well as to investigate the risk of ventricular repolarization using the Tpeak-Tend (Tp-e) interval and Tp-e/QT ratio in patients with epileptic disorder. A total of 63 patients receiving AED therapy and 35 healthy adults were included. ECG recordings were obtained before and 3 months after anti-epileptic treatment among patients with epilepsy. For both groups, Tp-e and Tp-e/QT ratio were measured using a 12-lead ECG device. Tp-e interval, Tpe/QT and Tp-e/QTc ratios were found to be higher in the patient group than in the control group (p<0.05, for all), while QTmax ratio was significantly lower in the patient group. After 3 months of AED therapy, significant increases in QT max, QTc max, QTcd, Tp-e, Tp-e/QT, and Tp-e/QTc were found among the patients (p<0.05). When the arrhythmic effects of the drugs before and after treatment were compared, especially in the valproic acid group, there were significant increases in Tp-e interval, Tp-e/QT and Tp-e/QTc values after three months of treatment (p<0.05). Carbamazepine and levetiracetam groups were not statistically significant in terms of pre- and post-treatment values. It was concluded that an arrhythmogenic environment may be associated with the disease, and patients who received AED monotherapy may need to be followed up more closely for arrhythmia.


  • Open Access

    Do antiepileptic drugs have any effect on Neutrophil / Lymphocyte and Platelet / Lymphocyte Ratio?

    by İlHan Çağ, Yaşar Altun, Erman Altunışık

    Objective: The aim of this study was to compare the complete blood count values of 40 healthy individuals and 60 patients who are using antiepileptic drugs (AEDs), specifically to evaluate neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR), platelet-lymphocyte ratio (PLR), and basophil-lymphocyte ratio (BLR). This study is important because it is the first study on hematological parameters such as NLR, MLO, PLO and BLO. Material and Methods: In this study, hemogram and biochemical data of 17 patients who received carbamazepine (CBZ), 21 patients with valproic acid (VPA), 22 patients with levetiracetam (LEV) along with 40 healthy controls were gathered and compared. The differences between the groups were evaluated statistically. Results: No difference was present between the groups in terms of age or gender (p> 0.05). NLR was 2.19±1.42 for patients using CBZ, 1.64±1.34 for VPA users, 2.18±0.73 for LEV users and 2.04±0.85 for control group (p> 0.05). NLR, MLR, PLR and BLR were not significantly different from the control group. Conclusion: To our knowledge, no study has targeted the haematological effects of antiepileptics on NLR, MLR, PLR and BLR. This study was important because it is the first study the effect of various antiepileptics on the hematological parameters such as NLR, MLR, PLR, and BLR. We believe that our study will articulate new studies.

  • Open Access

    Can serum C-Reactive Protein and Procalcitonin levels associate with carpal tunnel syndrome?

    by Yaşar Altun, Ali Zeynal Abidin Tak

    Objective: The purpose of this study was to examine whether an increase occurs in serum C-reactive protein (CRP) and procalcitonin (PCT) levels in patients with carpal tunnel syndrome (CTS). Material and Methods: Thirty-six patients who have CTS due to electrophysiological tests and 40 healthy individuals were included the study. Boston Questionnaire (BQ) was used to assess the functional and clinical status of the patients. Also, CRP and PCT levels were investigated. Correlations between such parameters (electrophysiological findings, BQ results, and clinical findings) were evaluated. Results: CTS and control subjects had similar CRP levels, whereas there was significant elevation in PCT among CTS patients. Serum PCT activity did not correlate with subunits of BQ (p> 0.05). Conclusion: The results of this small study showed significant PCT increases in patients with CTS. Further studies in this regard may help to clarify the diagnostic and or follow-up value of PCT in patients with CTS.

  • Mid-term oral isotretinoin therapy causes a predominantly sensory demyelinating neuropathy

    by Yasar Altun, Esra Inan

    Aim - The purpose of this prospective study was to investigate whether mid-term treatment with oral isotretinoin may impact peripheral nerve function. Methods - In this study, we included 28 patients with no apparent neurological or neurophysiological findings. The patients received treatment with oral isotretinoin for papulopustular or nodulocystic acne. The patients with normal findings in the first examination were given 1 mg/kg/day oral isotretinoin. Neurological examinations and electroneurographic studies were performed before and 6 months after the onset of isotretinoin treatment. Results - Clinical examinations and electroneurographic evaluations prior to treatment revealed no abnormalities in any of the patients. However, 20 patients (72%) displayed one or more abnormal values in the tested parameters after treatment. Although the mean amplitudes of compound muscle action potential of the ulnar and median nerves did not vary, significant decreases were observed in the mean sensory conduction velocities of median, ulnar, sural, medial plantar, medial dorsal cutaneous, and dorsal sural nerves 6 months after the onset of treatment. Conclusion - Systemic use of isotretinoin may cause electroneurographic changes. Probable electroneurographic alterations may be detected at a much earlier period via dorsal sural nerve tracing when electrophysiological methods used in routine clinical practice cannot detect these changes.


  • Open Access

    Posterior Reversible Ensefalopati Sendromu (PRES) Olgularının Retrospektif Olarak Analizi: Acil Servis Başvuruları

    by İrfan Aydin, Yaşar Altun, Mehmet Kaan Poyraz, Abdullah Algın, Hüseyin Kafadar

    ÖZET Giriş; Posterior reversible ensefalopati sendromu (PRES) , nörolojik ve radyolojik bulguların eşlik ettiği geri döndürülebilir bir sendromdur. İlk olarak 1996 yılında Hınchey J ve ark. tarafından tanımlanan bu sendrom genellikle hipertansiyon, baş ağrısı, konfüzyon, konvülziyon,kusma ve görme bozukluğunun eşlik ettiği geri döndürülebilir bir hastalık olarak literatüre geçmiştir. Patofizyolojisinde iki hipotez öne sürülmüştür, birincisi aniden yükselen tansiyona bağlı olarak serebral hiperperfüzyon ve buna bağlı vazojenik ödem, ikincisi ise endojen ve eksojen toksinlerin neden olduğu endotel disfonksiyonudur. Klinik olarak çeşitli nörolojik semptomlarla karekterize olup, akut veya subakut gelişebilir. Birkaç saat sürebildiği gibi günler ve haftalarca da sürebilir.Gereç ve Yöntem; Bu çalışma 2012-2017 yılları arasında Adıyaman Üniversitesi Tıp Fakültesi Acil Servise başvuran hastalar arasından retrospektif olarak yapıldı. Baş ağrısı, ensefalopati, nöbet, görme bozukluğu veya fokal nörolojik defekti içeren akut başlangıçlı nörolojik semptomlar ve beyin görüntülemesinde fokal vazojenik ödem tespit edilen beş PRES olgusu çalışmaya alındı. Olgular yaş, cinsiyet, acil servise başvuru şikayeti,kronik hastalık, gebelik durumu, BBT,MR ve elektroensefalografik (EEG) bulgularına göre sınıflandırıldı.Sonuç olarak; acil servise baş ağrısı, görme kaybı, bilinç kaybı ve özellikle konvülziyonla başvuran kadın ve gebelerde PRES akla gelmelidir. Anahtar Kelimeler: PRES, acil servis, konvülziyon ABSTRACT Background: Posterior reversible encephalopathy syndrome (PRES) is a reversible syndrome accompanied by neurological and radiological findings by Hynchy J et al. in 1996 . This syndrome is often referred with hypertension, headache, confusion, convulsions, vomiting, and loss of vision.Two hypotheses have been proposed for pathophysiology. The first being cerebral hyperperfusion due to suddenly elevated blood pressure and the associated vasogenic edema and the second endothelial dysfunction caused by endogenous and exogenous toxins. It is clinically characterized by various neurological findings which may develop acutely or subacutely. It can last for several hours or days and weeks.Material and method: This study was retrospectively performed between Adiyaman University Faculty of Medicine Emergency Service between 2012-2017. Acute onset neurological symptoms including headache, encephalopathy, seizure, visual impairment or focal neurologic deficit, and five PRES cases with focal vasogenic edema on brain imaging were included in the study. The cases were classified according to age, gender, complaint of emergency service, chronic disease, pregnancy status, BBT, MR and electroencephalographic (EEG) findings.Conclusion: As a result; emergency headache, visual loss, loss of consciousness, and PRES in women and pregnant women, especially those who are referred for convulsions. Keywords: PRES,emergency, convulsions

  • The Effects of Levetiracetam, Carbamazepine, and Sodium Valproate on P100 and P300 in Epileptic Patients

    by Yener Tumay, Yaşar Altun, Kazm Ekmekci, Yasar Ozkul

    Although the unfavorable effects of early antiepileptic drugs, valproic acid, and carbamazepine (CBZ) on cognitive functions and visual functions have been investigated, the unfavorable effects of levetiracetam (LEV) on cognitive and visual functions remain unknown. The aim of the present study is to investigate whether there is a difference between the adverse effects by comparing the P300 and P100 latencies of LEV with epileptic patients using CBZ or sodium valproate (VPA) and healthy subjects. A control group of 20 healthy subjects and 53 patients receiving monotherapy with CBZ (n = 15), VPA (n = 14), and LEV (n = 24) who admitted to neurology policlinic for investigation and treatment were enrolled in this study. Visual evoked potentials and event-related evoked potentials were studied according to these groups. Standard "oddball paradigm" (unpredictable stimuli series) was used to obtain P300. The P300 latencies of epileptic patients receiving CBZ, VPA, and LEV were longer compared with the control group, and the differences were statistically significant (P = 0.001, 0.001, and 0.03, respectively). The P300 latency of patients receiving LEV was significantly shorter than the group receiving CBZ and VPA with statistically significant difference (P < 0.01 for both). The P300 amplitude was lower in the groups receiving CBZ, VPA, and LEV compared with the control group, and the difference was statistically significant (P < 0.05). The present study shows that LEV disrupts P300 latency less than VPA and CBZ and does not prolong P100 as much as them.